Abstract
A boy, now 22 months old, is described who presented at the age of 6 weeks with hypoglycaemic coma. The excretion pattern of organic acids in the urine was consistent with glutaric aciduria type II (GA II). A high energy diet low in fat and protein was given.
Treatment with riboflavine resulted in an improvement of the metabolite profile, and the patient gained weight. However, a tendency to hypoglycaemia and severe hypotonia persisted. Due to muscle weakness, aggravated by infections, artificial ventilation was necessary during three periods.
Serum carnitine level was low. Treatment with carnitine, started during the third period of artificial ventilation, led to some improvement of muscle strength, but he still could not breathe without support. Treatment with insulin, combined with further enrichment of the diet with glucose, resulted in an increase in muscular strength and in weight gain.
Thirteen families with GA II have been described upto now. This is the first patient with a severe form of the disorder wo has survived the 1st year of life. Treatment and metabolic studies are presented.
Similar content being viewed by others
References
Barth PG, Scholte HR, Berden JA, Van der Kley-Van Moorsel JM, Luyt-Houwen IEM, Van 't Veer-Korthof ETh, Van der Harten JJ, Sobotka-Plojhar MA (1983) An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. J Neurol Sci 62:327–355
Besrat A, Polan CE, Henderson LM (1969) Mammalian metabolism of glutaric acid. J Biol Chem 244:1461–1467
Christensen E (1983) Glutaric aciduria type II: evidence for a defect in the electron transfer protein or in its dehydrogenase, 21th. Ann Symp SSIEM, Lyon, Abstr D-18
Coudé FX, Ogier H, Charpentier C, Thomassin G, Checoury A, Amedee-Manesme O, Saudubray JM, Frezal J (1981) Neonatal glutaric aciduria type II: an X-linked recessive inherited disorder. Hum Genet 59:263–265
Dusheiko G, Kew MC, Joffe BI, Lewin JR, Mantagos S, Tanaka K (1979) Recurrent hypoglycemia associated with glutaric aciduria type II in an adult. N Engl J Med 301:1405–1409
Goodman SI, McCabe ERB, Fenessey PV, Mace JW (1980) Multiple acyl-CoA dehydrogenase deficiency (glutaric aciduria type II) with transient hypersarcosinemia and sarcosinuria; possible inherited deficiency of an electron transfer flavoprotein. Pediatr Res 14:12–17
Goodman SI, Stene DO, McCabe ERB, Norenberg MD, Shikes RH, Stumpf DA, Blackborn GK (1982) Glutaric acidemia type II: clinical biochemical and morphologic considerations. J Pediatr 100:946–950
Goodman SI, Reale M, Berlow S (1983) Glutaric acidemia type II: a form with deleterious intrauterine effects. J Pediatr 102:411–413
Hall CL (1981) Electron transfer flavoprotein from pig liver mitochondria. Methods Enzymol 71:386–390
Gregersen N, Kølvraa S, Rasmussen K, Christensen E, Brandt NJ, Ebbesen F, Hansen FH (1980) Biochemical studies in a patient with defects in the metabolism of acyl-CoA and sarcosine: another possible case of glutaric aciduria type II. J Inherited Metab Dis 3:67–72
Gregersen N, Wintzensen H, Kølvraa S, Christensen E, Christensen MF, Brandt NJ, Rasmussen K (1982) C6-C10-Dicarboxylic aciduria: investigations of a patient with riboflavin responsive multiple acyl-CoA dehydrogenation defects. Pediatr Res 16:861–868
Kamerling JP, Duran M, Bruinvis L, Ketting D, Wadman SK, De Groot JC, Hommes FA (1977) (2-Ethoxyethoxy) acetic acid: An unusual compound found in the gaschromatographic analysis of urinary organic acids. Clin Chim Acta 77:397–405
Lehnert W, Wendel U, Lindenmaier S, Böhm N (1982) Multiple acyl-CoA dehydrogenation deficiency (glutaric aciduria type II), congenital polycystic kidneys and symmetric warty dysplasia of the cerebral cortex in two brothers. Eur J Pediatr 139:56–59
Mantagos S, Genel M, Tanaka K (1979) Ethylmalonic-adipic aciduria: in vivo and in vitro studies indicating deficiency of activities of multiple acyl-CoA dehydrogenases. J Clin Invest 64:1580–1589
Mitchell G, Saudubray JM, Benoit Y, Rocchíccioli F, Charpentier C, Ogier H, Boue J (1983) Antenatal diagnosis of glutaric aciduria type II. Lancet I:1099
Mooy PD, Scholte HR, Przyrembel H, Blom W, Giesberts MAH, Luyt-Houwen IEM, Van Gelderen HH (1984) Glutaric aciduria type II: Multiple defects in isolated muscle mitochondria and deficient beta-oxidation in fibroblasts. J Inher Metab Dis 7 (Suppl 2):101–102
Niederwieser A, Steinmann B, Exner U, Neuheiser F, Redweik U, Wang M, Rampini S, Wendel U (1983) Multiple acyl-CoA dehydrogenation deficiency (MADD) in a boy with nonketotic hypoglycemia, hepatomegaly, muscle hypotonia and cardiomyopathy. Helv Paediatr Acta 38:9–26
Przyrembel H, Wendel U, Becker K, Bremer HJ, Bruinvis L, Ketting D, Wadman SK (1979) Glutaric aciduria type II: report on a previously undescribed metabolic disorder. Clin Chim Acta 66:227–239
Rhead W, Mantagos S, Tanaka K (1980) Glutaric aciduria type II: in vitro studies on substrate oxidation, acyl-CoA dehydrogenases and electron-transferring flavoprotein in cultured skin fibroblasts. Pediatr Res 14:1339–1342
Roe CR, Bohan TP (1982) l-Carnitine therapy in propionic acidaemia. Lancet I:1411–1412
Sweetman L, Nyhan WL, Trauner DA, Merritt TA, Singh M (1980) Glutaric aciduria type II. J Pediatr 96:1020–1026
Teijema HL, Van Gelderen HH, Giesberts MAH (1980) Hypoketosis as a cause of symptoms in childhood hypoglycemia. Eur J Pediatr 134:51–55
Vamecq J, Van Hoof F (1983) Possible implications in glutaric aciduria of a novel peroxisomal enzyme, 21th. Ann Symp SSIEM, Lyon, Abstr 64
Wendel U, Langenbeck U, Lombeck I, Bremer HJ (1982) Maple syrup urine disease-therapeutic use of insulin in catabolic states. Eur J Pediatr 139:172–175
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mooy, P.D., Przyrembel, H., Giesberts, M.A.H. et al. Glutaric aciduria type II: treatment with riboflavine, carnitine and insulin. Eur J Pediatr 143, 92–95 (1984). https://doi.org/10.1007/BF00445792
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00445792